Home › Breast Cancer › NCT05978128

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates

Who can join

Ages 40 to 80 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Age:

  * Breast screening \> 40
  * Lung screening 50-80
* Male (M) or Female (F)
* Current, former, or never smokers
* Close family or friend with smoking history (in or out of state)

Exclusion Criteria:

* Age:

  * Breast screening \< 40
  * Lung screening \< 50 or \> 80
* Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded
* Persons with an active cancer

About the study

This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.

What is being tested

• Health Education (behavioral)
• Health Promotion and Education (other)
• Patient Navigation (behavioral)
• Survey Administration (other)

Sponsor: Jonsson Comprehensive Cancer Center · Participants: 800 · Started: Jul 28, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05978128

Locations in the U.S.

Conditions

• Breast Cancer
• Lung Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.